tacrolimus 5 MG Oral Capsule [Prograf]

Verify with CMS →

tacrolimus

RxCUI: 108514

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
2.1%
Plan Coverage
104
Plans Covering
T3.7
Avg Tier
100%
Prior Auth Required

What the CMS Formulary Data Shows for tacrolimus 5 MG Oral Capsule [Prograf]

Per the CMS 2026 Part D formulary file, tacrolimus 5 MG Oral Capsule [Prograf] (RxNorm concept RXCUI 108514, generic name tacrolimus) appears on 7 distinct formulary files spanning 104 Medicare Part D plan offerings - 2.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.7.

Real-world access to tacrolimus 5 MG Oral Capsule [Prograf] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 204,385 Part D beneficiaries filled tacrolimus 5 MG Oral Capsule [Prograf] in 2023, with total plan-and-beneficiary spending of $103,329,148 and an average per-beneficiary annual cost of $505.56. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry tacrolimus 5 MG Oral Capsule [Prograf] today.

Coverage Details

Formularies covering
7
Plans covering
104
Coverage rate
2.1%
Tier range
Tier 1 – Tier 5
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
100% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
204,385
Total spending
$103,329,148
Avg per beneficiary
$505.56

Tier Distribution Across Plans

3 plans
Tier 1, Preferred Generic
74 plans
Tier 4, Non-Preferred
23 plans
Tier 5, Specialty

Medicare Advantage Plans (MA-PD) Covering tacrolimus 5 MG Oral Capsule [Prograf]

100 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Hamaspik Medicare Choice (HMO D-SNP) HAMASPIK, INC. T1 Yes $0 NY
CalOptima Health OneCare Complete (HMO D-SNP) ORANGE COUNTY HEALTH AUTHORITY T1 Yes $0 CA
Hamaspik Medicare Select (HMO D-SNP) HAMASPIK, INC. T1 Yes $34.50 NY
SCAN Connections (HMO D-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Connections at Home (HMO D-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN NEVADA, INC. T4 Yes $0 NV
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN NEVADA, INC. T4 Yes $0 NV
SCAN Strive (HMO C-SNP) SCAN HEALTH PLAN NEVADA, INC. T4 Yes $0 NV
SCAN MyChoice (HMO) SCAN HEALTH PLAN NEVADA, INC. T4 Yes $0 NV
SCAN Classic (HMO) SCAN DESERT HEALTH PLAN, INC. T4 Yes $0 AZ
SCAN Balance (HMO C-SNP) SCAN DESERT HEALTH PLAN, INC. T4 Yes $0 AZ
SCAN Embrace (HMO-POS I-SNP) SCAN DESERT HEALTH PLAN, INC. T4 Yes $0 AZ
SCAN Strive (HMO C-SNP) SCAN DESERT HEALTH PLAN, INC. T4 Yes $0 AZ
SCAN MyChoice (HMO) SCAN DESERT HEALTH PLAN, INC. T4 Yes $0 AZ
SCAN Classic WA (HMO) SCAN HEALTH PLAN (WA) T4 Yes $0 WA
SCAN MyChoice WA (HMO) SCAN HEALTH PLAN (WA) T4 Yes $0 WA
SCAN Classic (HMO) SCAN HEALTH PLAN (NM) T4 Yes $0 NM
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN (NM) T4 Yes $0 NM
SCAN Strive (HMO C-SNP) SCAN HEALTH PLAN (NM) T4 Yes $0 NM
SCAN MyChoice (HMO) SCAN HEALTH PLAN (NM) T4 Yes $0 NM
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Prime (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Alta (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Venture (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Venture (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Embrace (HMO I-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Embrace (HMO I-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Embrace (HMO-POS I-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Affirm partnered with Included LGBTQ+ Health (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Affirm partnered with Included LGBTQ+ Health (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Strive (HMO C-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Strive (HMO C-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Inspired by women for women (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T4 Yes $0 CA
SCAN Affirm partnered with Included LGBTQ+ Health (HMO) SCAN HEALTH PLAN T4 Yes $0 CA

Frequently Asked Questions

Is tacrolimus 5 MG Oral Capsule [Prograf] covered by Medicare Part D?

Yes, tacrolimus 5 MG Oral Capsule [Prograf] is covered by 104 Medicare Part D plans (2.1% of all Part D formularies).

What tier is tacrolimus 5 MG Oral Capsule [Prograf] on Medicare Part D plans?

tacrolimus 5 MG Oral Capsule [Prograf] averages Tier 3.7 across Part D plans, ranging from Tier 1 to Tier 5.

Does tacrolimus 5 MG Oral Capsule [Prograf] require prior authorization?

100% of Part D formularies require prior authorization for tacrolimus 5 MG Oral Capsule [Prograf]. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on tacrolimus 5 MG Oral Capsule [Prograf]?

In 2023, total Medicare Part D spending on tacrolimus 5 MG Oral Capsule [Prograf] was $103,329,148, covering 204,385 beneficiaries. The average spend per beneficiary was $505.56.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial